Topfond Pharmaceutical Co., Ltd.

This product is an antibacterial drug. Escherichia coli is mostly sensitive to this product, and some strains of Enterobacteriaceae such as Enterobacter aerogenes, Enterobacter cloacae, Proteus, and Klebsiella are sensitive to this product. Aeruginosa is usually resistant to this product. This product has antibacterial effects on Gram-positive bacteria such as Enterococcus. The antibacterial activity of this product is not affected by pus and tissue decomposition products. It is more active in acidic urine. The antibacterial mechanism is to interfere with the oxidoreductase system in the bacteria, thereby blocking its metabolic process.

Doxazosin tablets are long-acting a1-receptor blockers. This product selectively acts on postganglionic a1-adrenergic receptors, causing peripheral vasodilation, reducing peripheral vascular resistance and lowering blood pressure, with little effect on cardiac output. Like other a1-receptor blockers, doxazosin has a greater effect on standing blood pressure and heart rate. This product acts on the a1-adrenergic receptors of the prostate and bladder neck smooth muscles, relaxing the bladder neck, prostate, and prostate capsule smooth muscles, reducing urethral and bladder resistance, and thus alleviating urethral obstruction symptoms caused by prostate hyperplasia. This product can slightly reduce total cholesterol (2-3%), LDL-cholesterol (4%), and slightly increase HDL-cholesterol (4%). However, the clinical significance of these changes is still unclear.

Participates in bone formation and reconstruction of bone tissue after fracture, as well as muscle contraction, nerve transmission, coagulation mechanism and reduces capillary permeability, etc.

It is a local irritant that can selectively act on the cold receptors of the mucosa, produce a cold reflex, cause the mucosal blood vessels to contract, and produce a therapeutic effect. It has a cooling effect on the mucosa; it can cause blood vessels to contract and reduce edema when used on inflamed mucosa.

The active ingredient of this product, menthol, is a local irritant. When used locally, it can selectively act on the cold receptors of the mucosa, produce a cold reflex, cause the mucosal blood vessels to contract, and produce a therapeutic effect. When used on the mucosa, it has a cooling effect; when used on inflamed mucosa, it can cause blood vessels to contract and reduce edema.

The active ingredient of this product, menthol, is a local irritant. When used locally, it can selectively act on the cold receptors of the mucosa, produce a cold reflex, cause the mucosal blood vessels to contract, and produce a therapeutic effect. When used on the mucosa, it has a cooling effect; when used on inflamed mucosa, it can cause blood vessels to contract and reduce edema.

It combines with pyrophosphate in the body to form a coenzyme, and participates in the oxidative decarboxylation reaction of pyruvate and α-ketoglutarate in sugar metabolism. It is necessary for sugar metabolism. When it is deficient, oxidation is blocked, resulting in the accumulation of pyruvate and lactic acid, which affects the body's energy supply and may cause symptoms related to the nervous, cardiovascular and digestive systems.